期刊文献+

B淋巴细胞的活化标志及其在慢性肾衰竭的临床意义 被引量:1

Activation marker for B lymphocyte and its clinical significance in chronic renal failure
下载PDF
导出
摘要 目的 以CD2 3分子作为B淋巴细胞活化的标志 ,观察慢性肾衰 (CRF)维持性血液透析 (HD)患者B淋巴细胞激活状态。方法 以金黄色葡萄球菌CowanI株菌体 (SAC)与健康人外周血单个核细胞 (PBMC)数 5 0∶1的比例 ,以终浓度 5 0 μg/L的佛波醇酯 (PMA)分别培养PBMC 12h、2 4h和 5 0h ;用生物素链霉亲和素免疫细胞化学法 (BSA ICC)检测CD2 3 +细胞百分率 ;以速率散射比浊法检测SAC或PMA刺激 5 0h的上清液中IgG水平 ;以双抗体夹心ELASA检测血清可溶性CD2 3 (sCD2 3 )。结果 未经刺激的健康人和CRF HD患者PBMC中CD2 3 +细胞百分率分别为 ( 6.6± 0 .9) %和 ( 17.9± 3 .7) %差异有显著性 (P <0 .0 1)。健康人PBMC经SAC刺激12h、2 4h、5 0h后CD2 3 +细胞百分率分别为 ( 8.8± 1.7) %、( 13 .0± 1.6) %和 ( 16.2± 1.9) % ,与无药对照管比较差异有显著性 (P <0 .0 1) ;经PMA刺激 12h、2 4h后CD2 3 +细胞百分率分别为 ( 17.0± 2 .3 ) %、( 3 1.5± 2 .9) % ,与无药对照管比较差异有非常显著性 (P <0 .0 0 1) ;经SAC或PMA刺激 5 0h培养上清液IgG含量分别为 ( 9.1± 4.6) g/L和 ( 14.6± 5 .7)g/L ,后者与无药对照管 ( 7.3± 3 .7g/L)差异有显著性 (P <0 .0 1)。健康人和CRF HD患者血清sCD2 3含量分别为 ( 1.8± 0 . Objective To observe the preactivation status of B cells from chronic renal failure hemodialysis (CRF-HD) patients, with CD23 molecule as an activation marker of B lymphocyte. Methods The peripheral blood mononuclear cells (PBMCs) from healthy volunteers (HVs) were stimulated with SAC (SAC to PBMC was in the ratio of 50 to 1) or PMA (final concentration 50 μg/L) and were harvested in 12 h, 24 h and 50 h respectively. The percentage of CD23 positive cells in PBMCs were detected with biotin-streptavidin immunocytochemistry (BSA-ICC) method, The IgG in supernantant of cultured PBMCs stimulated with SAC or PMA for 50 h was measured with rate immuno-nephelometry method. The soluble CD23 (sCD23) in serum from patients and heathy volunteers was determined with double antibody sandwich ELISA. Results The percentages of CD23 positive cells in unstimulated PBMCs from HVs and CRF-HD patients were 6.6±0.9% and 17.9±3.7% respectively, there was significat difference (P<0.01). The percentages of CD23 positive cells in PBMCs from HVs stimulated with SAC for 12 h, 24 h and 50 h were 8± 1.7%, 13.0±1.6% and 16.2±1.9% respectively, there was significant difference, compared with unstimulated control (P<0.01). The pecentages of CD23 positive cells in PBMCs from HVs stimulated with PMA for 12 h and 24 h were 17.0±2.3% and 31.5±2.9%, there was extremely significant difference, compared with unstimulated control (P<0.001). The IgG concentrations in supernatant of cultured PBMCs stimulated with SAC or PMA for 50 h were 9.1 g/L and 14.6±5.7 g/L respectively, the later was compared with unstimulated control (7.3±3.7 g/L), there was significat difference (P<0.01). The concentrations of sCD23 in serum from HVs and CRF-HD patients were 1.8±0.1 U/ml and 13.7±5.0 U/ml respectively, there was extremely significant difference (P<0.001). Conclusions SAC or PMA are possessed of the strog function activating B lymphocytes and promoting the expression of CD23 molecule and IgG synthesis. There is preactivation status of B lymphocytes of CRF-HD patients, it is one of causes leading to immune function disorder of CRF-HD patients.
出处 《上海医学检验杂志》 北大核心 2003年第2期90-93,共4页 Shanghai Journal of Medical Laboratory Sciences
关键词 B淋巴细胞 活化标志 慢性肾衰竭 临床意义 B lymphocyte CD23 Soluble CD23 Staphylococcus aureus Cowan I Phorbol-12-myristate-13-acetate
  • 相关文献

参考文献10

  • 1Thorley-Lawson DA, Nadler LM, Bhan AK, et al.BLAST-2 [ EBVCS], an early cell surface marker of human Bcell activation, is superinduced by Epsstein Barr virus[J]. J Immunol, 1985, 134:3007-3012.
  • 2晋康新,李淑艳,徐德胜.CD23研究进展[J].国外医学(免疫学分册),2000,23(1):47-51. 被引量:5
  • 3Huissoon AP, Emery P, Bacon PA, et al. Increased expression of CD23 in rhematoid synovitis[J ]. Scand J Rheumatol, 2000, 29 : 154-159.
  • 4张丁丁,伍卫林,杨明清.类风湿性关节炎患者sCD23测定的临床意义[J].中国免疫学杂志,2000,16(7):396-397. 被引量:2
  • 5朱晴晖,陆俊茜,吴海辉,郑茉莉,李灼亮,涂荫国.用BSA系统免疫细胞化学法检测人外周血T和B淋巴细胞群[J].上海医学检验杂志,1993,8(4):210-211. 被引量:24
  • 6刘恭值,许化溪,章谷生,等.现代医学免疫学[M].南京:江苏科学技术出版社,2000.135.
  • 7Ribben C, Bonnet V, Kaiser M J, et al. Increased synoveal fluid levels of soluble CD23 are associated sith an drosive status in rheumatiod arthritis (RA) [ J 1.Clinical Clin Exp lmmunol, 2000, 120: 194-199.
  • 8Descamps Latscha B, Herbelin A, Nguyen AT, et al.Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis[J]. Kidney lnt, 1993,43:878-884.
  • 9Beaurain G, Naret, Marcon L, et al. In vivo T cell activation In chronic uremic hemodialyzed and nonhemodialyzed patients[ J ]. Kidney Int, 1989, 36 : 636-644.
  • 10Rezzonico R, Chicheportiche R, Imbert V, et al. Engagement of CDllb and CD1 lc beta 2 integrin by antibodies or soluble CD23 induces IL-1 beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways[J ]. Blood, 2000,95:3868-3877.

二级参考文献4

共引文献28

同被引文献2

  • 1Schwarzmeier J D, Shehata M, Hilgarth M, et al. The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia[J]. Leukemia and Lymphoma,2002,43(3):549-554.
  • 2Hubmann R, Schwarzmeier J. D, Shehata M, et al. Notch 2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia[J]. Blood, 2002, 99 (10): 3742-3747.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部